Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human MAP1A ELISA Kit (AC2960)
Cat.#: ASET-1549
Specifications
Description Human MAP1A ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human MAP1A concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.09 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 2.5-40 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1899 Human Vimentin ELISA Kit (AC3310) Quantitative inquiry ASET-2142 Human BACE1 ELISA Kit (AC3553) Quantitative inquiry ASET-1355 Human Prion Protein PrP ELISA Kit (AC2766) Quantitative inquiry ASET-1263 Human GPR37L1 ELISA Kit (AC2674) Quantitative inquiry ASET-1941 Mouse TrkB ELISA Kit (AC3352) Quantitative inquiry ASET-1302 Mouse Laminin alpha 1 ELISA Kit (AC2713) Quantitative inquiry ASET-1346 Mouse Chromogranin B ELISA Kit (AC2757) Quantitative inquiry ASET-1964 Human Prol1 ELISA Kit (AC3375) Quantitative inquiry ASET-1386 Mouse NMDAR1 ELISA Kit (AC2797) Quantitative inquiry ASET-1344 Rat Dopamine Transporter ELISA Kit (AC2755) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket